Companies / Spain
Multinationals Change Strategy For Local Market
November 2006 | Company Finance AlertReports in the Spanish press suggest that Janssen-Cilag, Eli Lilly and Merck & Co have joined fellow multinational drugmaker Pfizer in adopting a controversial new distribution model for the local market. The strategy envisages directly distributing pharmaceuticals to retail pharmacies, thereby cutting out wholesalers, who are blamed for their role in Europe's US$5bn 'parallel trade'. The practice allows arbitrageurs to export valuable medicines from lower-priced markets to other destinations in the EU, creating severe losses for
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
